Gerhard Scherhorn, 21 February 1930–28 February 2018
نویسندگان
چکیده
منابع مشابه
CombinaTexas 2018 February 10 – 11 , 2018
In this talk we give combinatorial proofs of q-Stirling identities using restricted growth words. This includes a poset theoretic proof of Carlitz’s identity, a new proof of the q-Frobenius identity of Garsia and Remmel and of Ehrenborg’s Hankel q-Stirling determinantal identity. We also develop a two parameter generalization to unify identities of Mercier and include a symmetric function versi...
متن کاملIn the literature: February 2018
Correspondence to Professor Andrés Cervantes; andres. cervantes@ uv. es Liquid biopsies may identify minimaL residuaL disease after reseCtion in Lung CanCer Non-invasive liquid biopsies may transform the management of patients with cancer. Circulating tumour DNA (ctDNA) derived from cancer cells can be identified in most patients with advanced cancer, representing a potential non-invasive sourc...
متن کاملLecture 9 — February 21
In this lecture, we will define different types of alignments and explain some of their properties. We begin with a suitable alphabet Σ. Throughout the discussion, we will choose Σ = {A,C,G, T}, the four nucleotides, although note that the definitions hold for all finite alphabets. Examples of other alphabets include Σ′ = {A,C,G, T,N}, where N denotes an unknown base. The alphabet Σ′ is widely ...
متن کاملBurns Evidence Update February 2018 ( Quarterly )
Introduction: Severe burns result in prolonged hypermetabolism and skeletal muscle catabolism. Rehabilitative exercise training (RET) programs improved muscle mass and strength in severely burned children. The combination of RET with A-blockade or testosterone analogs showed improved exercise-induced benefits on body composition and muscle function. However, the effect of RET combined with mult...
متن کاملHuntington’s Disease Clinical Trials Corner: February 2018
In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTTRX trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Consumer Policy
سال: 2018
ISSN: 0168-7034,1573-0700
DOI: 10.1007/s10603-018-9373-4